Next Generation Left Atrial Appendage Implant to Treat Persistent Atrial Fibrillation

Project description

Novel medical implant for atrial fibrillation

Fields of science

• medical and health sciences › clinical medicine › cardiology › cardiovascular diseases › cardiac arrhythmia
• medical and health sciences › clinical medicine › surgery
• medical and health sciences › basic medicine › neurology › stroke
• medical and health sciences › medical biotechnology › implants

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

AURIGEN MEDICAL LIMITED

Net EU contribution

€ 2 452 165,38

Address

18 Churchwell Square
DUBLIN 13 Dublin
Ireland

Region

Ireland › Eastern and Midland › Dublin

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 1 050 928,02